- Locations
- Asia Pacific
- Accelerating patient access to precision oncology in Asia Pacific (Summary)
Get instant access
Precision oncology can offer a path forward, delivering more targeted treatment options that will redefine the medical paradigm for cancer patients, and reduce the economic burden of cancer care. The advent of powerful Next-Generation Sequencing (NGS) technologies has led to the discovery of tumors with rare genomic signatures and can also enable better-informed treatment decisions. However, there are challenges to the uptake of precision oncology in APAC, including health technology assessments (HTA) and reimbursement of precision oncology, as well as clinical and data infrastructure.
To read the full white paper click here
This article was produced as part of the IQVIA APAC Insight magazine, to read the full publication please click here